An epigenetic clock is an algorithm that estimates biological age from the pattern of chemical methyl tags on your DNA. It reads how heavily methylated a defined set of sites in the genome is, usually from a blood sample, and converts that pattern into a number expressed in years. Different clocks are trained on different targets: some to predict calendar age, some to predict disease and mortality risk, and one family to estimate how fast you are aging right now. The deeper reference entry on the Epigenetic clock covers each of the major clocks in turn.
What it measures
The raw input is DNA methylation: methyl groups attached to cytosine bases, mostly at CpG sites. Methylation at many of these sites drifts in a fairly orderly way across the lifespan, so a statistical model trained on thousands of samples can read the pattern backwards and output an age estimate. Depending on the clock, the model uses anywhere from a few dozen to several hundred CpG sites.
In practice the test is a blood draw, a saliva kit or a tissue sample, processed on a methylation array or by sequencing. The number you get back is not measured the way glucose is. It is the output of a formula, and it inherits every quirk of the data that formula was trained on.
Typical values
Results are reported in three different formats, and they answer different questions:
| Output | Unit | How to read it |
|---|---|---|
| Epigenetic age (DNAm age) | Years | The clock’s estimate of your age from methylation alone |
| Age acceleration | Years | Epigenetic age minus chronological age; positive means the clock reads older than you are |
| Pace of aging | Years of aging per calendar year | Around 1.0 is the cohort average; higher means faster |
There is no clinical cut-off. Consumer reports vary between providers, between array versions and even between two samples from the same person taken days apart, because the technical noise in a single CpG measurement is real. Treat one result as a rough reading, not a verdict, and compare only results from the same provider using the same clock. The pace-of-aging approach, DunedinPACE — the clock of the pace of aging, was designed partly to be more stable on repeat testing than the older age-estimating clocks.
Why it matters for longevity
In large observational cohorts, people whose epigenetic age runs ahead of their chronological age have higher rates of death and of age-related disease, including cardiovascular disease, some cancers and dementia. Second-generation clocks trained on clinical biomarkers and mortality generally predict outcomes better than the first-generation clocks trained only on calendar age.
What has not been shown is that lowering your clock reading lowers your risk. That step requires trials with hard endpoints, and those do not yet exist. An epigenetic clock is a marker under study, not a validated surrogate for how long you will live.
What changes it
Chronological age is by far the largest driver, and nothing changes that. Beyond it, smoking shows up strongly, especially on the clocks built to capture mortality risk, and quitting is the single clearest lever. Obesity, heavy alcohol intake, poor sleep and chronic inflammation are all associated with faster clock readings in observational data.
Small randomized trials have reported modest slowing of some clocks with caloric restriction, with omega-3 and vitamin D supplementation, and with structured aerobic training. The changes are small, the trials are short, and none of them tracked lifespan. The habits that move an epigenetic clock are the same ones that move blood pressure, fitness and metabolic health. Act on those directly, and use the clock, if at all, as a slow-moving second opinion.
Related reading
- Epigenetic Clocks: Measuring Age from DNA
- What Biological Age Is and How to Measure It
- Aerobic Training Slowed the Epigenetic Clock
- Omega-3 Slowed Biological Aging in the DO-HEALTH Trial
Disclaimer. This article is for information only and does not replace medical advice. Talk to a qualified clinician before changing anything about your health.